Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Genomic Landscape of Young ATLL Patients Identifies Frequent Targetable CD28 Fusions

Noriaki Yoshida, MD PhD, Kay Shigemori, Samuel Y. Ng, MD PhD, Ajit Nirmal, PhD, Nicolas Donaldson, Nicolas Cordero, Kristen E. Stevenson, MS, Xia Bu, Mai Takeuchi, MD PhD, Koichi Ohshima, MD PhD, Akinori Yoda, PhD, David M Weinstock

Blood (2019) 134 (Supplement_1): 2760.

https://doi.org/10.1182/blood-2019-122525

Published: 2019

Journal Articles

In Vitro andpre-Clinical In Vivo evidence Support MDMX/MDM2 As Common Vulnerabilities across TP53 -Wild-Type T-Cell Lymphomas That Are Targetable with the α-Helical p53 Stapled Peptide Alrn-6924

Raphael Koch, MD, Amanda L Christie, BS, Noriaki Yoshida, MD PhD, Samuel Y. Ng, MDPhD, Kay Shigemori, Sara N Morrow, Alexandria Van Scoyk, Steven M. Horwitz, MD, Eric Jacobsen, MD, Solimar Santiago, Jian-Guo Ren, Vincent Guerlavais, PhD, D. Allan Annis, Manuel A. Aivado, MD PhD, David M. Weinstock, MD

Blood (2017) 130 (Supplement 1): 571.

https://doi.org/10.1182/blood.V130.Suppl_1.571.571

Published: 2017

Journal Articles

Expression Pattern of Immunosurveillance-Related Antigen Is a Critical Prognostic Factor of Adult T-Cell Leukemia/Lymphoma

Naoko Asano, MD PhD, Hiroaki Miyoshi, MD PhD, Takeharu Kato, MD, Joji Shimono, MD, Noriaki Yoshida, MD PhD, Daisuke Kurita, MD, Yuya Sasaki, MD, Keisuke Kawamoto, MD, Koichi Ohshima, MD PhD, Masao Seto, MD PhD

Blood (2016) 128 (22): 4135.

https://doi.org/10.1182/blood.V128.22.4135.4135

Published: 2016

Journal Articles

Immunohistochemical Expression Pattern of Programmed Cell Death Ligand 1 Might be Both Good and Bad Prognostic Factor in Adult T-Cell Leukemia/ Lymphoma

Miyoshi Hiroaki, MD PhD, Junichi Kiyasu, MD, Takeharu Kato, MD, Noriaki Yoshida, MD PhD, Daisuke Kurita, MD, Sasaki Yuya, MD, Koji Kato, MDPhD, Yoshitaka Imaizumi, MD PhD, Masao Seto, MD PhD, Koichi Akashi, MD PhD, Koichi Ohshima, MD PhD

Blood (2015) 126 (23): 3891.

https://doi.org/10.1182/blood.V126.23.3891.3891

Published: 2015

Journal Articles

Clinical Significance of MYC, BCL2 and BCL6 Rearrangement and Protein Expression in GCB and Non-GCB Type Diffuse Large B-Cell Lymphoma

Keisuke Kawamoto, MD, Jun Takizawa, MD, Hiroaki Miyoshi, MD, Noriaki Yoshida, MD, Yasuhiko Shibasaki, MD, Masayoshi Masuko, MD, Hirohito Sone, MD, Naoya Nakamura, MD PhD, Koichi Ohshima, MD PhD

Blood (2015) 126 (23): 1445.

https://doi.org/10.1182/blood.V126.23.1445.1445

Published: 2015

Journal Articles

STX11 Acts As a Novel Tumor Suppressor Gene in Peripheral T-Cell Lymphomas

Noriaki Yoshida, MD, Shinobu Tsuzuki, MD PhD, Kennosuke Karube, MD PhD, Miyuki Katayama, MD PhD, Taishi Takahara, MD, Shigeo Nakamura, MD PhD, Momoko Nishikori, MD, PhD, Masanori Shimoyama, MD PhD, Koichi Ohshima, MD PhD, Kunihiro Tsukasaki, MD PhD, Masao Seto, MD PhD

Blood (2014) 124 (21): 1615.

https://doi.org/10.1182/blood.V124.21.1615.1615

Published: 2014

Journal Articles

FDC Like Cell Line HK With IL-2, IL-4 and OX40 Ligand Supports The Growth Of ATLL Cells

Yoshitoyo Kagami, MD, Dai Chihara, MD, Harumi Kato, M.D, Ph.D., Noriaki Yoshida, MD, Tomohiro Kinoshita, MD, PhD, Masao Seto, MD, PhD

Blood (2013) 122 (21): 4319.

https://doi.org/10.1182/blood.V122.21.4319.4319

Published: 2013

Journal Articles

Cell Cycle Deregulation Determines Acute Transformation In Chronic Type Adult T-Cell Leukemia/Lymphoma

Noriaki Yoshida, MD, Kennosuke Karube, MD, PhD, Atae Utsunomiya, M.D., PhD, Kunihiro Tsukasaki, MD, PhD, Yoshitaka Imaizumi, MD, PhD, Naoya Taira, MD, PhD, Naokuni Uike, MD, PhD, Akira Umino, MD, Kotaro Arita, MD, Miyuki Suguro, MD, PhD, Shinobu Tsuzuki, MD, PhD, Tomohiro Kinoshita, MD, PhD, Koichi Ohshima, MD, PhD, Masao Seto, MD, PhD

Blood (2013) 122 (21): 845.

https://doi.org/10.1182/blood.V122.21.845.845

Published: 2013

Journal Articles

Identification of Multiple Subclones in Peripheral T-Cell Lymphoma, Not Otherwise Specified with Genomic Aberrations

Noriaki Yoshida, MD, Akira Umino, MD, Fang Liu, MD, PhD, Kotaro Arita, MD, Kennosuke Karube, MD, PhD, Shinobu Tsuzuki, MD, PhD, Koichi Ohshima, MD, PhD, Masao Seto, MD, PhD

Blood (2012) 120 (21): 298.

https://doi.org/10.1182/blood.V120.21.298.298

Published: 2012

Journal Articles

Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)

Taiichi Kyo, MD, Noriaki Yoshida, MD, Kouhei Kyo, MD, Takeshi Okatani, MD, Mitsuhiro Itagaki, MD, Hiromi Yuasa, MD, Koji Iwato, MD, Hideki Asaoku, MD, Yuuta Katayama, MD

Blood (2010) 116 (21): 2934.

https://doi.org/10.1182/blood.V116.21.2934.2934

Published: 2010

Journal Articles

Establishment of An HS23 Stromal Cell-Dependent Myeloma Cell Line: Fibronectin and IL-6 Are Critical for Survival

Akira Sakai, MD, PhD, Miyo Oda, PhD, Noriaki Yoshida, MD, Mitsuhiro Itagaki, MD, Koji Arihiro, MD, PhD, Akiro Kimura, MD, PhD

Blood (2010) 116 (21): 2949.

https://doi.org/10.1182/blood.V116.21.2949.2949

Published: 2010

Journal Articles

High Remission Rates and Long-Term Survival in a High Percentage of Patients Achieved by Intensive Chemotherapy for AML and Further Improvement of Supportive Care.

Taiichi Kyo, MD, Akiko Kimura, MD, Kouhei Kyo, MD, Noriaki Yoshida, MD, Hideki Asaoku, MD, Koji Iwato, MD, Yuuta Katayama, MD, Hiromi Yuasa, MD

Blood (2009) 114 (22): 1052.

https://doi.org/10.1182/blood.V114.22.1052.1052

Published: 2009

Journal Articles

Levels of sIL-2R in Sera Depend On Number of CD25-Positive Lymphoma Cells and MMP-9-Positive Macrophages in DLBCL.

Noriaki Yoshida, MD, Akira Sakai, MD, PhD, Yoshiko Okikawa, MD, Yuta Katayama, MD, PhD, Hideki Asaoku, MD, Hirotaka Matsui, MD, PhD, Koji Arihiro, MD, PhD, Megumu Fujihara, MD, PhD, Takashi Nishisaka, MD, PhD, Naomi Sasaki, MD, PhD, Yoshito Sadahira, MD, PhD, Akiro Kimura, MD, PhD

Blood (2009) 114 (22): 2927.

https://doi.org/10.1182/blood.V114.22.2927.2927

Published: 2009

Journal Articles

Cytomegalovirus Infection in Patients with Acute Leukemia and MDS.

Hiromi Yuasa, M.D., Ph.D., Taiichi Kyo, MD, Noriaki Yoshida, MD, Yuta Katayama, Hideki Asaoku, MD

Blood (2009) 114 (22): 4167.

https://doi.org/10.1182/blood.V114.22.4167.4167

Published: 2009

Journal Articles

Significance of Serum Soluble IL-2R in DLBCL and FL Is Different from That in ATL

Noriaki Yoshida, MD, Akira Sakai, MD, PhD, Yoshiko Okikawa, MD, Hideaki Nitta, MD, Takashi Nishisaka, MD, PhD, Akiro Kimura, MD, PhD

Blood (2008) 112 (11): 2817.

https://doi.org/10.1182/blood.V112.11.2817.2817

Published: 2008

NARROW

Genomic Landscape of Young ATLL Patients Identifies Frequent Targetable CD28 Fusions

In Vitro andpre-Clinical In Vivo evidence Support MDMX/MDM2 As Common Vulnerabilities across TP53 -Wild-Type T-Cell Lymphomas That Are Targetable with the α-Helical p53 Stapled Peptide Alrn-6924

Expression Pattern of Immunosurveillance-Related Antigen Is a Critical Prognostic Factor of Adult T-Cell Leukemia/Lymphoma

Immunohistochemical Expression Pattern of Programmed Cell Death Ligand 1 Might be Both Good and Bad Prognostic Factor in Adult T-Cell Leukemia/ Lymphoma

Clinical Significance of MYC, BCL2 and BCL6 Rearrangement and Protein Expression in GCB and Non-GCB Type Diffuse Large B-Cell Lymphoma

STX11 Acts As a Novel Tumor Suppressor Gene in Peripheral T-Cell Lymphomas

FDC Like Cell Line HK With IL-2, IL-4 and OX40 Ligand Supports The Growth Of ATLL Cells

Cell Cycle Deregulation Determines Acute Transformation In Chronic Type Adult T-Cell Leukemia/Lymphoma

Identification of Multiple Subclones in Peripheral T-Cell Lymphoma, Not Otherwise Specified with Genomic Aberrations

Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)

Establishment of An HS23 Stromal Cell-Dependent Myeloma Cell Line: Fibronectin and IL-6 Are Critical for Survival

High Remission Rates and Long-Term Survival in a High Percentage of Patients Achieved by Intensive Chemotherapy for AML and Further Improvement of Supportive Care.

Levels of sIL-2R in Sera Depend On Number of CD25-Positive Lymphoma Cells and MMP-9-Positive Macrophages in DLBCL.

Cytomegalovirus Infection in Patients with Acute Leukemia and MDS.

Significance of Serum Soluble IL-2R in DLBCL and FL Is Different from That in ATL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only